Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
dopamiiniagoniste ja teisi dopamiinergilist ravi nagu entakapooni koos levodopaga raviks saavatel parkinsoni tõve haigetel on kirjeldatud patoloogilist hasartmängurlust, suurenenud libiidot ja hüperseksuaalsust.
pathological gambling, increased libido and hypersexuality have been reported in parkinson’ s disease patients treated with dopamine agonists and other dopaminergic treatments such as entacapone in association with levodopa.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità:
sagedamini patsientidel, kes said entakapooni ja dopamiiniagoniste (nt bromokrüptiin), selegiliini või amantidiini võrreldes nende patsientidega, kes said samas kombinatsioonis platseebot.
patients who received entacapone and dopamine agonists (such as bromocriptine), selegiline or amantadine compared to those who received placebo with this combination.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità:
dopamiiniagoniste ja teist dopamiinerigilist ravi nagu entakapooni koos levodopaga, ja seda eriti just suurtes annustes, raviks saavatel parkinsoni tõve haigetel on kirjeldatud väljendunud patoloogilist hasartmängurlust, suurenenud libiidot ja hüperseksuaalsust, mis olid üldiselt taanduvad kas ravimi annuste vähendamise või ravi katkestamisega.
parkinson’ s disease patients treated with dopamine agonists and other dopaminergic treatments such as entacapone in association with levodopa, especially at high doses, have been reported as exhibiting signs of pathological gambling, increased libido and hypersexuality, which were generally reversible upon reduction of the dose or treatment discontinuation.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità:
kliiniliste uuringute põhjal avaldusid soovimatud dopamiinergilised rektsioonid nagu düskineesia sagedamini patsientidel, kes said entakapooni ja dopamiiniagoniste (nt bromokrüptiin), selegiliini või amantadiini võrreldes nende patsientidega, kes said samas kombinatsioonis platseebot.
in clinical studies, dopaminergic adverse reactions, e.g. dyskinesia, were more common in patients who received entacapone and dopamine agonists (such as bromocriptine), selegiline or amantadine compared to those who received placebo with this combination.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità: